Hallett David

Hallett David is listed in filings as Chief Scientific Officer at Recursion Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including 5 public disclosures. Recent filings connect the profile to Recursion Pharmaceuticals, Inc. (RXRX). The current snapshot covers public activity from Feb 10, 2026 to May 19, 2026. Reported amounts are shown as $81.0K to $45.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.